Client Story
Trial Interactive Client Spotlight
![Trial Interactive Expedites FDA Approval](/sites/default/files/styles/1000px_wide_webp/public/2023-04/ti_karyopharm_spotlight_0.png.webp?itok=15-94O6h)
TransPerfect assisted Karyopharm Therapeutics in expediting the FDA drug approval process for myeloma patients. Karyopharm approached TransPerfect with two challenges: preparing their trial master file (TMF) for inspections and translating over 60,000 words of critical documentation for an NDA submission within a weekend. Utilizing their Trial Interactive technology, TMF services, and translation expertise, TransPerfect enabled Karyopharm to meet the FDA's deadlines and successfully submit their drug application. As a result, Karyopharm's first product, XPOVIO, received FDA approval.
![Webinar cover image](themes/custom/tpls/assets/img/webinar-cover.png)